One signaling pathway that has recently drawn much attention for this purpose is the PI3K/AKT/mTOR axis and abnormal activation of this pathway has been reported to play an important role in progression, metastasis, and also chemoresistance in a variety of tumors including bladder cancer (22–26). This evidence concerns the gene AKT1 and urinary bladder cancer.